BryodulcosigeninCAS# 4965-97-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 4965-97-3 | SDF | Download SDF |
PubChem ID | 441813 | Appearance | Powder |
Formula | C30H50O4 | M.Wt | 474.72 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3S,8S,9R,10R,13R,14S,17R)-17-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one | ||
SMILES | CC(CCC(C(C)(C)O)O)C1CCC2(C1(CC(=O)C3(C2CC=C4C3CCC(C4(C)C)O)C)C)C | ||
Standard InChIKey | FPMQKXQOBKDVHF-ZGUWQJCPSA-N | ||
Standard InChI | InChI=1S/C30H50O4/c1-18(9-13-24(32)27(4,5)34)19-15-16-28(6)22-12-10-20-21(11-14-23(31)26(20,2)3)30(22,8)25(33)17-29(19,28)7/h10,18-19,21-24,31-32,34H,9,11-17H2,1-8H3/t18-,19-,21-,22+,23+,24?,28+,29-,30+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Bryodulcosigenin has anti-inflammatory effect, it shows potent inhibitory effects on EBV-EA induction. |
Targets | Immunology & Inflammation related |
Bryodulcosigenin Dilution Calculator
Bryodulcosigenin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1065 mL | 10.5325 mL | 21.065 mL | 42.1301 mL | 52.6626 mL |
5 mM | 0.4213 mL | 2.1065 mL | 4.213 mL | 8.426 mL | 10.5325 mL |
10 mM | 0.2107 mL | 1.0533 mL | 2.1065 mL | 4.213 mL | 5.2663 mL |
50 mM | 0.0421 mL | 0.2107 mL | 0.4213 mL | 0.8426 mL | 1.0533 mL |
100 mM | 0.0211 mL | 0.1053 mL | 0.2107 mL | 0.4213 mL | 0.5266 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Nephthenol
Catalog No.:BCN8647
CAS No.:53915-41-6
- 14,15beta-Dihydroxyklaineanone
Catalog No.:BCN8646
CAS No.:137359-82-1
- 1''-O-beta-D-glucopyranosylformoside
Catalog No.:BCN8645
CAS No.:148245-77-6
- (1S,2S)-threo-Honokitriol
Catalog No.:BCN8644
CAS No.:1099687-80-5
- Caesappanin C
Catalog No.:BCN8643
CAS No.:1913319-59-1
- Myrrhone
Catalog No.:BCN8642
CAS No.:183551-83-9
- Lancifodilactone C
Catalog No.:BCN8641
CAS No.:663176-26-9
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
- Glabrone
Catalog No.:BCN8639
CAS No.:60008-02-8
- Bruceoside A
Catalog No.:BCN8638
CAS No.:63306-30-9
- Veratrosine
Catalog No.:BCN8637
CAS No.:475-00-3
- (Z)-Aldosecologanin
Catalog No.:BCN8636
CAS No.:82474-97-3
- Euphorbia factor L7b
Catalog No.:BCN8649
CAS No.:93550-95-9
- Nortracheloside
Catalog No.:BCN8650
CAS No.:33464-78-7
- 1-Methyl-6-oxopyridine-3-carboxylic acid
Catalog No.:BCN8651
CAS No.:3719-45-7
- Daidzein diacetate
Catalog No.:BCN8652
CAS No.:3682-01-7
- 11alpha-Methoxysaikosaponin F
Catalog No.:BCN8653
CAS No.:104109-37-7
- Angelicolide
Catalog No.:BCN8654
CAS No.:90826-58-7
- 5-Ethoxy-10-Gingerol
Catalog No.:BCN8655
CAS No.:121771-98-0
- Ginsenoside Rh7
Catalog No.:BCN8656
CAS No.:343780-68-7
- Kanzonol C
Catalog No.:BCN8657
CAS No.:151135-82-9
- Nuezhenidic acid
Catalog No.:BCN8658
CAS No.:183238-67-7
- Vinaginsenoside R4
Catalog No.:BCN8659
CAS No.:156009-80-2
- Bacopaside I
Catalog No.:BCN8660
CAS No.:382148-47-2
Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica.[Pubmed:11858752]
J Nat Prod. 2002 Feb;65(2):179-83.
Seven new triterpene glycosides, bryoniosides A-G (1-7), have been isolated along with two known triterpene glycosides, cabenoside D (8) and bryoamaride (9), from a methanol extract of the roots of Bryoniadioica. The structures of 1-7 were determined on the basis of spectroscopic and chemical methods. Six compounds, 2, 3, 5, and 7-9, and 11 compounds, 1-9, Bryodulcosigenin (10), and bryosigenin (11), respectively, were evaluated for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation (1 microg/ear) in mice and on Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA. All compounds tested showed marked anti-inflammatory effects, with 50% inhibitory doses (ID(50)) of 0.2-0.6 mg per ear. In addition, all of the compounds tested except for compound 5 showed potent inhibitory effects on EBV-EA induction (100% inhibition at 1 x 10(3) mol ratio/TPA).